MHRA transparency data on clinical trials for medicines: authorisation assessment performance (Cell and Gene Therapy Catapult – Regulatory Round-up – April 2022)
The MHRA published its latest transparency data relating to clinical trials for medicines: authorisation assessment performance on 13 Apr 2022.
See all of Catapult’s Regulatory Round-up for April 2022 here.
Published on the 29th of April 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (3 août 2022). MHRA transparency data on clinical trials for medicines: authorisation assessment performance (Cell and Gene Therapy Catapult – Regulatory Round-up – April 2022). ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/o61s
